CSL Behring is a specialty biotherapeutics company built on more than a century of service to people with serious medical conditions around the world. Biotherapies differ from conventional chemical-based pharmaceuticals in that they derive from human blood plasma or are manufactured using recombinant technologies. CSL Behring is proud to serve communities of people who have von Willebrand disease (VWD), hemophilia, immunodeficiency, and other rare diseases. We also manufacture biotherapies to prevent or stop bleeding in emergencies or planned surgery.
Achieving better health
CSL Behring's R&D efforts have resulted in a wide range of products that have had a lasting impact on human health around the world.
Making a difference with one treatment at a time
We bring to market treatments for rare diseases.
Our commitment and delivering our promise
We are committed to delivering value through fulfilling unmet needs and enhancing the patient experience. We provide medicines that help people with life-threatening medical conditions.
CSL Behring Product Portfolio
CSL Behring is a biotechnology company that has been serving people who have serious medical conditions around the world for more than a century.
For products registered in other Asia South countries, please contact our local partners for more information.
Report an adverse drug reaction
If you encounter any side effect(s) to a CSL Behring product, we encourage you to talk to your doctor, pharmacist, or nurse, and please report your event to PhV-ECI@cslbehring.com.
CSL Behring collects information about adverse drug reactions in order to monitor product safety and investigate, evaluate and report adverse drug reactions to appropriate regulatory bodies. You may find out more about how we handle your personal information here.